DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma eIF3a in DLBC: Prognostic Biomarker +Therapeutic Target Apr 30, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Enhancing CAR-T Therapy With Nivolumab: Final Analysis Apr 25, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Combination Therapy: HDT/ASCT With CNCT19 Apr 25, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Predictive Model: DLBCL Mortality Risk Factors Apr 23, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Addressing R/R DLBCL Therapy in Older Patients Apr 12, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma TIM3/Galectin-9 Shows Promise in CD8+TIL Exhaustion & DLBCL Apr 10, 2024
Lymphoma,MZL (Marginal Zone Lymphoma) IRTA1 Positivity in PCMZL: Implications Beyond IgM Expression Apr 10, 2024
